Online Inquiry
Cat.#: ACPP-1213
| Despition | CACNB2 Blocking Peptide for Immmunodepletion, Competition Assay |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1165 | Recombinant Mouse PGRPS Protein (Fc Tag) (AC1165) | 50 µg | inquiry |
| ACPP-1686 | Human Acrp30 Protein, HEK (AC1686) | 2 µg | inquiry |
| ACPP-1048 | Recombinant Human Butyrylcholinesterase Protein (6×His Tag) (AC1048) | 50 µg | inquiry |
| ACPP-1838 | Human APO D Protein, GST (AC1838) | 2 µg | inquiry |
| ACPP-1713 | Human SNCB Protein (AC1713) | 10 µg | inquiry |
| ACPP-1594 | Human CCM2 Protein (AC1594) | 2 µg | inquiry |
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1265 | EDG8 Blocking Peptide (AC1265) | 250 µg | inquiry |
| ACPP-1610 | Mouse MANF Protein (AC1610) | 5 µg | inquiry |
| ACPP-1825 | Human ANKRA2 Protein (AC1825) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.